Rongyu Zhang

Shandong Province Key Laboratory Of Applied Mycology
Qingdao, 266109, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Unraveling the Mechanism of Perillyl Alcohol and Its Derivatives as Potent Antifungal Agents against Gray Mold.

Unraveling the Mechanism of Perillyl Alcohol and Its Derivatives as Potent Antifungal Agents against Gray Mold.

Journal: Journal of agricultural and food chemistry

Published: March 10, 2026

Cost-effectiveness of first-line osimertinib plus chemotherapy versus amivantamab plus lazertinib for advanced EGFR-mutant NSCLC in the US and China.

Cost-effectiveness of first-line osimertinib plus chemotherapy versus amivantamab plus lazertinib for advanced EGFR-mutant NSCLC in the US and China.

Journal: Therapeutic advances in medical oncology

Published: February 27, 2026

A Case of Metastatic Non-small Cell Lung Cancer with Rare BRAF p.L485_T488delinsF Mutation Treated with Dabrafenib and Trametinib

A Case of Metastatic Non-small Cell Lung Cancer with Rare BRAF p.L485_T488delinsF Mutation Treated with Dabrafenib and Trametinib

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: October 29, 2025

Clinical outcomes and safety of continuous immunotherapy beyond progression in patients with extensive-stage small cell lung cancer: a retrospective real-world study.

Clinical outcomes and safety of continuous immunotherapy beyond progression in patients with extensive-stage small cell lung cancer: a retrospective real-world study.

Journal: Frontiers in immunology

Published: August 07, 2025

What is the best first-line combination regimen for advanced EGFR-mutated non-small cell lung cancer: a network meta-analysis and systemic review.

What is the best first-line combination regimen for advanced EGFR-mutated non-small cell lung cancer: a network meta-analysis and systemic review.

Journal: Frontiers in pharmacology

Published: February 06, 2025

Efficacy and safety of immunotherapy or antiangiogenic agent-based treatment strategies versus chemotherapy as first-line treatment for extensive-stage small cell lung cancer: a network meta-analysis.

Efficacy and safety of immunotherapy or antiangiogenic agent-based treatment strategies versus chemotherapy as first-line treatment for extensive-stage small cell lung cancer: a network meta-analysis.

Journal: Frontiers in pharmacology

Published: December 04, 2024

Effects of sweet potato starch on the physicochemical properties and edible qualities of instant fresh rice noodles.

Effects of sweet potato starch on the physicochemical properties and edible qualities of instant fresh rice noodles.

Journal: International journal of biological macromolecules

Published: June 30, 2024

Efficacy and patient-reported outcomes in advanced non-small cell lung cancer patients receiving aumolertinib as first-line therapy: a real-world study.

Efficacy and patient-reported outcomes in advanced non-small cell lung cancer patients receiving aumolertinib as first-line therapy: a real-world study.

Journal: Frontiers in pharmacology

Published: June 06, 2024

Efficacy and safety of novel immune checkpoint inhibitor-based combinations versus chemotherapy as first-line treatment for patients with extensive-stage small cell lung cancer: A network meta-analysis.

Efficacy and safety of novel immune checkpoint inhibitor-based combinations versus chemotherapy as first-line treatment for patients with extensive-stage small cell lung cancer: A network meta-analysis.

Journal: Thoracic cancer

Published: February 22, 2024

Construction and In Vitro Digestibility of Recrystallized Starch Encapsulated in Calcium Alginate Beads.

Construction and In Vitro Digestibility of Recrystallized Starch Encapsulated in Calcium Alginate Beads.

Journal: Foods (Basel, Switzerland)

Published: May 08, 2023

Showing 1-10 of 10

Last Updated: 09/26/2026